LP-10
Safety and Efficacy of LP-10
Phase 2 small_molecule completed
Quick answer
LP-10 for Hemorrhagic Cystitis is a Phase 2 program (small_molecule) at LIPELLA PHARMACEUTICALS INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIPELLA PHARMACEUTICALS INC.
- Indication
- Hemorrhagic Cystitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed